
Joint Venture and Patent Grant Mark Jointechlabs’ Entry Into China Regenerative Medicine Microfat Market
Jointechlabs has been granted a core Chinese patent and has entered into a joint venture to develop the microfat market in China.
Read moreJointechlabs has been granted a core Chinese patent and has entered into a joint venture to develop the microfat market in China.
Read moreJointechlabs has released new components and standardized processing to reduce time, complexity, and cost of microfat-based regenerative medicine procedures.
Read moreNew syringes and a choice of cannulas will make adipose processing faster and personalized to each physician’s needs.
Read moreJointechlabs earned the MDSAP quality certification indicating compliance with ISO13485:2016 for medical device quality management.
Read moreEuropean focus includes a new subsidiary in Austria, a medical research center in partnership with a prominent health center, and development and distribution agreements for Germany, Austria, Switzerland, Italy, Spain, and the Balkans. CHICAGO, OCT. 20, 2022/PRNewswire/–Jointechlabs, Inc., a Regenerative Medicine Solutions company announced a Vienna-based subsidiary named JointechPlus GmbH. They also announced research, development, […]
Read moreJointechlabs has just strengthened its intellectual property position with the granting of a new US patent covering systems and methods of encapsulating stem cells.
Read moreDrs. Katz and Guarino demonstrate the operation of MiniTC.
Read moreCritical skin wounds are a major cost for the health sector and lead to immense suffering for the patients. One way to facilitate the healing of these wounds is through autologous adipose tissue transplants. However, the implanted tissue needs to be vascularized or it will suffer from necrosis. To combat this Stromal vascular fraction (SVF), […]
Read moreTreating patients with OA presents a significant challenge for physicians as no therapies to date have demonstrated efficacy in curing or even halting disease progression. Therefore, most approaches initially target pain management and factors that may be exacerbating stress on the joint. https://dx.doi.org/10.2147%2FSCCAA.S68073 – Mayo Clinic, MN Corticosteroid toxicity for chondrocytes has been long reported, both […]
Read moreKatz, N., Koukharenko, V. and Geldner, P2,3. Laboratory of Stem cells and Bioengineering, Jointechlabs, Inc., Skokie, IL North Michigan Surgical Center, Chicago, IL Geldner Center, Chicago, IL Introduction: Fat auto graft transplantation method for different reconstructive plastic surgeries has been fueled recently by encouraging reports from Japan, the United Kingdom, the United States, and others. […]
Read more